UK tribunal upholds CMA pharma collusion fine
The UK’s Competition Appeal Tribunal has confirmed the Competition and Markets Authority’s finding that Lexon colluded with rival drug suppliers to keep up prices of an antidepressant sold to the National Health Service.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10